Lmr Partners LLP Kymera Therapeutics, Inc. Transaction History

Lmr Partners LLP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$49.91 - $65.56 $3.29 Million - $4.32 Million	-65,941 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$47.8 - $66.66 $1.87 Million - $2.61 Million	39,161 Added 146.23%	65,941 $3.87 Million
Q2 2021 Aug 16, 2021	BUY	$31.08 - $51.95 $832,322 - $1.39 Million	26,780 New	26,780 $1.3 Million

182

65.3M

50.6K

81.7K

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $1.92B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.